Skip to main content

Table 3 Primary endpoint: safety

From: A-Part Gel, an adhesion prophylaxis for abdominal surgery: a randomized controlled phase I–II safety study [NCT00646412]

  A-Part-Gel (N = 31) Control (N = 29)
Wound healing impairment and /or peritonitis 2 (6.5 %) 4 (13.8 %)
90% CI [0.012, 0.189] 90 % CI [0.049, 0.288]
Peritonitis 1 (3.2 %) 0 (0.0 %)
90 % CI [0.002, 0.144] 90 % CI [0.000, 0.098]
Delayed wound healing 2 (6.5 %) 4 (13.8 %)
90 % CI [0.012, 0.189] 90 % CI [0.049, 0.288]
Surgical site infection 1 (3.2 %) 3 (10.3 %)
90 % CI [0.002, 0.144] 90 % CI [0.029, 0.249]
Impaired wound healing 2 (6.5 %) 4 (13.8 %)
90 % CI [0.012, 0.189] 90 % CI [0.049, 0.288]
Anastomotic leakage 3 (9.7 %) 3 (10.3 %)
90 % CI [0.027, 0.232] 90 % CI [0.029, 0.246]